Overview
Availability
- Associate Professor Helmut Schaider is:
- Available for supervision
Qualifications
- Bachelor of Medicine, Karl-Franzens- Universität Graz
- Certificate of Dermatology, unknown
Works
Search Professor Helmut Schaider’s works on UQ eSpace
2020
Journal Article
Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants
Rayner, Jenna E., Duffy, David L., Smit, Darren J., Jagirdar, Kasturee, Lee, Katie J., De’Ambrosis, Brian, Smithers, B. Mark, McMeniman, Erin K., McInerney-Leo, Aideen M., Schaider, Helmut, Stark, Mitchell S., Soyer, H. Peter and Sturm, Richard A. (2020). Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants. PLoS ONE, 15 (9) e0238529, e0238529. doi: 10.1371/journal.pone.0238529
2020
Journal Article
Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls
Duffy, David L., Jagirdar, Kasturee, Lee, Katie J., McWhirter, Seamus R., McMeniman, Erin K., De’Ambrosis, Brian, Pflugfelder, Annette, Rayner, Jenna E., Whiteman, David C., Brown, Matthew A., Martin, N.G., Smithers, B.M., Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2020). Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls. Journal of Investigative Dermatology, 140 (2), 498-501.e17. doi: 10.1016/j.jid.2019.05.032
2020
Journal Article
Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer
Menon, Dinoop Ravindran, Hammerlindl, Heinz, Torrano, Joachim, Schaider, Helmut and Fujita, Mayumi (2020). Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics, 10 (14), 6261-6277. doi: 10.7150/thno.42523
2019
Journal Article
Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”
Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, Peter H. and Smithers, Mark B. (2019). Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”. Journal of Surgical Oncology, 120 (6), 1058-1059. doi: 10.1002/jso.25686
2019
Journal Article
Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer
Al Emran, Abdullah, Marzese, Diego M., Menon, Dinoop R., Hammerlindl, Heinz, Ahmed, Farzana, Richtig, Erika, Duijf, Pascal, Hoon, Dave S. B. and Schaider, Helmut (2019). Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer. Epigenomics, 11 (7), 723-737. doi: 10.2217/epi-2018-0173
2019
Journal Article
Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization
Heitzer, Ellen, Groenewoud, Arwin, Meditz, Katharina, Lohberger, Birgit, Liegl-Atzwanger, Bernadette, Prokesch, Andreas, Kashofer, Karl, Behrens, Diana, Haybaeck, Johannes, Kolb-Lenz, Dagmar, Koefeler, Harald, Riedl, Sabrina, Schaider, Helmut, Fischer, Carina, Snaar-Jagalska, B. Ewa, de’Jong, Danielle, Szuhai, Karoly, Zweytick, Dagmar and Rinner, Beate (2019). Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization. Scientific Reports, 9 (1) 4096, 4096. doi: 10.1038/s41598-019-40570-1
2019
Journal Article
Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
Torrano, Joachim, Al Emran, Abdullah, Hammerlindl, Heinz and Schaider, Helmut (2019). Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming. Clinical Epigenetics, 11 (1) 43, 43. doi: 10.1186/s13148-019-0644-y
2019
Journal Article
Cover image
Emran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang and Schaider, Helmut (2019). Cover image. Cancer Medicine, 8 (3), i-i. doi: 10.1002/cam4.2129
2019
Journal Article
Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma
Emran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang and Schaider, Helmut (2019). Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma. Cancer Medicine, 8 (3), 1186-1196. doi: 10.1002/cam4.1978
2019
Journal Article
A systematic review and meta-analysis of locoregional treatments for in-transit melanoma
Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2019). A systematic review and meta-analysis of locoregional treatments for in-transit melanoma. Journal of Surgical Oncology, 119 (7) jso.25686, 887-896. doi: 10.1002/jso.25400
2019
Journal Article
The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review
Deen, Jacqueline and Schaider, Helmut (2019). The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review. Australasian Journal of Dermatology, 60 (3), e186-e194. doi: 10.1111/ajd.12992
2019
Conference Publication
ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care setting
Economides, A., Mar, V., Soyer, H. P., Schaider, H., Sadeghi, M. and Guitera, P. (2019). ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care setting. 2019 Dermcoll, Melbourne, Australia, 18 – 21 May 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.
2019
Conference Publication
Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanoma
Faleiro, Rebecca J., Karunarathne, Deshapriya S., Liu, Ji, Boyle, Glen, Hartel, Gunter, Hayward, Nick, Schaider, Helmut, Waddell, Nic, Schmidt, Chris and Wykes, Michelle (2019). Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Atlanta, GA, United States, 29 March - 3 April, 2019. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-4112
2019
Conference Publication
Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanoma
Spoerri, L., Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Smith, A., Scott, E., Schaider, H., Gabrielli, B., Weninger, W. and Haass, N. (2019). Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanoma. 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Munich, Germany, 13-16 March, 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.13859
2018
Journal Article
Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma
Laino, Antonia, Shepherd, Benjamin, Atkinson, Victoria, Fu, Hong, Soyer, H. Peter and Schaider, Helmut (2018). Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma. JAAD Case Reports, 4 (9), 921-923. doi: 10.1016/j.jdcr.2018.06.024
2018
Journal Article
‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi
Koh, Uyen, Janda, Monika, Aitken, Joanne F., Duffy, David L., Menzies, Scott, Sturm, Richard A., Schaider, Helmut, Betz-Stablein, Brigid, Prow, Tarl, Soyer, H. Peter and Green, Adele C. (2018). ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi. BMJ Open, 8 (9) e025857, e025857. doi: 10.1136/bmjopen-2018-025857
2018
Journal Article
Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms (vol 138, pg 1636, 2018)
Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms (vol 138, pg 1636, 2018). Journal of Investigative Dermatology, 138 (9), 2085-2085. doi: 10.1016/j.jid.2018.06.174
2018
Journal Article
An ex vivo human tumour assay reveals distinct patterns of EGFR trafficking in squamous cell carcinoma correlating to therapeutic outcomes
Joseph, Shannon R., Gaffney, Daniel, Barry, Rachael, Hu, Lingbo, Banushi, Blerida, Wells, James W., Lambie, Duncan, Strutton, Geoff, Porceddu, Sandro V., Burmeister, Bryan, Leggatt, Graham R., Schaider, Helmut, Dolcetti, Riccardo, Frazer, Ian H., Saunders, Nicholas A., Foote, Matthew, Soyer, H. Peter and Simpson, Fiona (2018). An ex vivo human tumour assay reveals distinct patterns of EGFR trafficking in squamous cell carcinoma correlating to therapeutic outcomes. Journal of Investigative Dermatology, 139 (1), 213-223. doi: 10.1016/j.jid.2018.06.190
2018
Journal Article
Focal regression of a primary melanoma, fading lentigines, and poliosis in metastatic melanoma treated with anti-PD-1
Thomas, S, Laino, A, Sturm, R, Nufer, K, Lambie, D, Shepherd, B, Atkinson, V, Adams, L, Soyer, H P and Schaider, H (2018). Focal regression of a primary melanoma, fading lentigines, and poliosis in metastatic melanoma treated with anti-PD-1. Journal of the European Academy of Dermatology and Venereology : JEADV, 32 (5), e176-e177. doi: 10.1111/jdv.14678
2018
Journal Article
Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers
Hammerlindl, Heinz, Ravindran Menon, Dinoop, Hammerlindl, Sabrina, Emran, Abdullah Al, Torrano, Joachim, Sproesser, Katrin, Thakkar, Divya, Xiao, Min, Atkinson, Victoria G., Gabrielli, Brian, Haass, Nikolas K., Herlyn, Meenhard, Krepler, Clemens and Schaider, Helmut (2018). Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers. Clinical Cancer Research, 24 (5), 1090-1102. doi: 10.1158/1078-0432.CCR-16-2118
Funding
Current funding
Supervision
Availability
- Associate Professor Helmut Schaider is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Proteomics and transcriptomics analysis of phenotypic heterogeneity in 3D melanoma spheroids
Associate Advisor
Other advisors: Dr Quan Nguyen, Professor Nikolas Haass
Completed supervision
-
2020
Master Philosophy
The role of SETDB1/2-mediated H3K9me3 in drug-tolerant cancer
Principal Advisor
Other advisors: Associate Professor Rick Sturm
-
2019
Doctor Philosophy
Characterizing therapy induced adaptive phenotypic plasticity leading to acquired drug resistance in cancer
Principal Advisor
Other advisors: Professor David Craik
-
2018
Doctor Philosophy
Distinct Epigenetic Modifications Denote Early Drug Resistance in Cancer
Principal Advisor
Other advisors: Professor Brian Gabrielli
-
2018
Master Philosophy
The correlation of skin colour, skin reflectance, freckling, MC1R, TYR, IRF-4 and TPCN2 genotypes with naevus pattern within a case-control study of melanoma
Principal Advisor
Other advisors: Associate Professor Rick Sturm
-
2017
Master Philosophy
The role of immune regulators in induced drug tolerant cells (IDTC) in melanoma
Principal Advisor
Other advisors: Associate Professor James Wells
-
2020
Master Philosophy
Resistance to therapy in metastatic melanoma: Comparing the expression of immune inhibitory modulators in vitro with refractory metastatic melanoma patients.
Associate Advisor
Other advisors: Associate Professor James Wells
-
2020
Doctor Philosophy
An evaluation of the role of locoregional treatments for the management of in-transit melanoma metastases
Associate Advisor
Other advisors: Professor Peter Soyer
-
2020
Doctor Philosophy
Enhanced topical drug delivery for treatment of human melanoma
Associate Advisor
Other advisors: Emeritus Professor Ross Barnard, Emeritus Professor Michael Roberts, Dr Yousuf Mohammed
-
2019
Doctor Philosophy
Investigation of Microphthalmia-Associated Transcription Factor (MITF)-driven tumour heterogeneity in a 3D melanoma spheroid model in vitro.
Associate Advisor
Other advisors: Professor Nikolas Haass
-
2019
Master Philosophy
Dissecting Molecular Events in Pregnancy-Associated Melanoma
Associate Advisor
Other advisors: Professor Kiarash Khosrotehrani
Media
Enquiries
For media enquiries about Associate Professor Helmut Schaider's areas of expertise, story ideas and help finding experts, contact our Media team: